Annual accounts receivable:
$4.74B-$6.93M(-0.15%)Summary
- As of today (May 29, 2025), TAK annual accounts receivable is $4.74 billion, with the most recent change of -$6.93 million (-0.15%) on March 1, 2025.
- During the last 3 years, TAK annual accounts receivable has fallen by -$1.08 billion (-18.53%).
- TAK annual accounts receivable is now -33.65% below its all-time high of $7.15 billion, reached on March 31, 2021.
Performance
TAK Accounts receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly accounts receivable:
$4.74B+$211.04M(+4.66%)Summary
- As of today (May 29, 2025), TAK quarterly accounts receivable is $4.74 billion, with the most recent change of +$211.04 million (+4.66%) on March 1, 2025.
- Over the past year, TAK quarterly accounts receivable has dropped by -$6.93 million (-0.15%).
- TAK quarterly accounts receivable is now -38.22% below its all-time high of $7.67 billion, reached on December 31, 2020.
Performance
TAK Quarterly accounts receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Accounts receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
TAK Accounts receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -0.1% | -0.1% |
| 3 y3 years | -18.5% | -18.5% |
| 5 y5 years | -28.4% | -28.4% |
TAK Accounts receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -18.5% | at low | -18.5% | +4.7% |
| 5 y | 5-year | -33.6% | at low | -38.2% | +4.7% |
| alltime | all time | -33.6% | +258.0% | -38.2% | +40.5% |
TAK Accounts receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | $4.74B(-0.1%) | $4.74B(+4.7%) |
| Dec 2024 | - | $4.53B(-7.6%) |
| Sep 2024 | - | $4.91B(+4.5%) |
| Jun 2024 | - | $4.69B(-1.1%) |
| Mar 2024 | $4.75B(-6.2%) | $4.75B(-6.5%) |
| Dec 2023 | - | $5.08B(+0.4%) |
| Sep 2023 | - | $5.06B(-7.7%) |
| Jun 2023 | - | $5.48B(+8.1%) |
| Mar 2023 | $5.06B(-13.0%) | $5.06B(-6.1%) |
| Dec 2022 | - | $5.39B(+2.6%) |
| Sep 2022 | - | $5.26B(-5.7%) |
| Jun 2022 | - | $5.58B(-4.1%) |
| Mar 2022 | $5.82B(-18.6%) | $5.82B(-6.4%) |
| Dec 2021 | - | $6.22B(-17.5%) |
| Sep 2021 | - | $7.54B(+0.7%) |
| Jun 2021 | - | $7.48B(+4.7%) |
| Mar 2021 | $7.15B(+8.0%) | $7.15B(-6.9%) |
| Dec 2020 | - | $7.67B(+7.6%) |
| Sep 2020 | - | $7.13B(-2.2%) |
| Jun 2020 | - | $7.29B(+10.2%) |
| Mar 2020 | $6.62B(+5.0%) | $6.62B(-12.2%) |
| Dec 2019 | - | $7.54B(+4.4%) |
| Sep 2019 | - | $7.22B(+2.5%) |
| Jun 2019 | - | $7.05B(+11.8%) |
| Mar 2019 | $6.30B(+81.1%) | $6.30B(+36.5%) |
| Dec 2018 | - | $4.62B(+13.8%) |
| Sep 2018 | - | $4.06B(-0.5%) |
| Jun 2018 | - | $4.08B(+17.3%) |
| Mar 2018 | $3.48B | $3.48B(-23.4%) |
| Dec 2017 | - | $4.54B(+9.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2017 | - | $4.15B(+4.4%) |
| Jun 2017 | - | $3.97B(+4.9%) |
| Mar 2017 | $3.79B(+2.5%) | $3.79B(-10.2%) |
| Dec 2016 | - | $4.22B(-2.2%) |
| Sep 2016 | - | $4.31B(+3.9%) |
| Jun 2016 | - | $4.15B(+12.3%) |
| Mar 2016 | $3.70B(-0.2%) | $3.70B(-8.0%) |
| Dec 2015 | - | $4.02B(+2.1%) |
| Sep 2015 | - | $3.94B(+4.7%) |
| Jun 2015 | - | $3.76B(+1.5%) |
| Mar 2015 | $3.70B(-11.5%) | $3.70B(-9.5%) |
| Dec 2014 | - | $4.09B(-1.6%) |
| Sep 2014 | - | $4.16B(-0.7%) |
| Jun 2014 | - | $4.19B(+0.2%) |
| Mar 2014 | $4.18B(+5.1%) | $4.18B(+2.6%) |
| Dec 2013 | - | $4.08B(+3.4%) |
| Sep 2013 | - | $3.94B(+5.8%) |
| Jun 2013 | - | $3.73B(-6.4%) |
| Mar 2013 | $3.98B(-8.2%) | $3.98B(-10.0%) |
| Dec 2012 | - | $4.42B(+2.7%) |
| Sep 2012 | - | $4.31B(-0.8%) |
| Mar 2012 | $4.34B(+28.6%) | $4.34B(+28.6%) |
| Mar 2011 | $3.37B(+71.4%) | $3.37B(-10.5%) |
| Dec 2008 | - | $3.77B |
| Mar 2007 | $1.97B(+11.7%) | - |
| Mar 2006 | $1.76B(-4.1%) | - |
| Mar 2005 | $1.84B(+7.0%) | - |
| Mar 2004 | $1.72B(+20.4%) | - |
| Mar 2003 | $1.43B(+7.6%) | - |
| Mar 2002 | $1.32B(-12.7%) | - |
| Mar 2001 | $1.52B | - |
FAQ
- What is Takeda Pharmaceutical Company Limited annual accounts receivable?
- What is the all time high annual accounts receivable for Takeda Pharmaceutical Company Limited?
- What is Takeda Pharmaceutical Company Limited annual accounts receivable year-on-year change?
- What is Takeda Pharmaceutical Company Limited quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Takeda Pharmaceutical Company Limited?
- What is Takeda Pharmaceutical Company Limited quarterly accounts receivable year-on-year change?
What is Takeda Pharmaceutical Company Limited annual accounts receivable?
The current annual accounts receivable of TAK is $4.74B
What is the all time high annual accounts receivable for Takeda Pharmaceutical Company Limited?
Takeda Pharmaceutical Company Limited all-time high annual accounts receivable is $7.15B
What is Takeda Pharmaceutical Company Limited annual accounts receivable year-on-year change?
Over the past year, TAK annual accounts receivable has changed by -$6.93M (-0.15%)
What is Takeda Pharmaceutical Company Limited quarterly accounts receivable?
The current quarterly accounts receivable of TAK is $4.74B
What is the all time high quarterly accounts receivable for Takeda Pharmaceutical Company Limited?
Takeda Pharmaceutical Company Limited all-time high quarterly accounts receivable is $7.67B
What is Takeda Pharmaceutical Company Limited quarterly accounts receivable year-on-year change?
Over the past year, TAK quarterly accounts receivable has changed by -$6.93M (-0.15%)